Clay Thorp

Affiliations

  • at Clearside Biomedical Inc. (CLSD), 2025-02-24
  • Director at Phasebio Pharmaceuticals Inc (PHAS), 2023-05-19
  • Director at Vigil Neuroscience Inc. (VIGL), 2022-05-18
  • Large Shareholder at G1 Therapeutics Inc. (GTHX), 2018-06-01
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CLSD $0.92 15,000 $13,800.00 176,141 2025-02-24 Filing
CLSD $0.86 10,000 $8,600.00 40,522 2023-09-25 Filing
CLSD $1.02 14,000 $14,266.00 30,522 2022-12-21 Filing
VIGL $2.97 14,893 $44,189.02 1,556,030 2022-05-17 Filing
VIGL $2.76 21,802 $60,221.48 1,541,137 2022-05-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CLSD $4.43 32,873 $145,627.39 4,951,547 2021-02-10 Filing
CLSD $4.43 32,873 $145,627.39 3,433,521 2021-02-10 Filing
PHAS $14.00 459 $6,426.00 415,959 2019-07-01 Filing
PHAS $14.00 255 $3,570.00 52,397 2019-07-01 Filing
PHAS $14.00 180 $2,520.00 162,890 2019-07-01 Filing